Results 171 to 180 of about 64,232 (227)

Haemophilus influenzae Type b Infections

Archives of Pediatrics & Adolescent Medicine, 1978
Sir .—The current interest in the literature 1-4 in the spread of Haemophilus type b infections prompted us to add our recent experience with this problem that tends to confirm previous observations. Three infants, ages of 10 and 17 months, were admitted within an eight-day period with serious Haemophilus influenzae type b infections, two with ...
N, Wycliffe, J, Landwirth
openaire   +2 more sources

Haemophilus influenzae Type b Osteomyelitis

Archives of Pediatrics & Adolescent Medicine, 1978
Three children had osteomyelitis due to Haemophilus influenzae type b. They were seen with signs and symptoms indistinguishable from infection caused by other organisms. One child was initially misdiagnosed as having septic arthritis because of failure to appreciate that Hemophilus may also cause bone infection.
D M, Granoff, E, Sargent, D, Jolivette
openaire   +2 more sources

Haemophilus influenzae Type b

1991
Invasive disease caused by Haemophilus influenzae type b (Hib) is recognized as a leading infectious disease health problem, primarily for young children (Table 1). An estimated 20,000 persons develop invasive Hib disease each year in the United States, and it has also been estimated that during the first 5 years of life the cumulative incidence of ...
Stephen L. Cochi, Joel I. Ward
openaire   +1 more source

Haemophilus Influenza Type b

Disease-a-Month, 2007
Susan Shoshana Weisberg, MD, FCP, FAAP aemophilus influenza type b is best known by its nickname, Hib. The influenza” in Hib’s formal name is actually a mistake. The Hib germ was rst discovered in 1892, in the middle of a flu epidemic, and it was first solated from the saliva of patients suffering from influenza.
openaire   +1 more source

Haemophilus influenzae type b conjugate vaccine

Journal of Pediatric Health Care, 1988
Abstract Hib conjugate vaccine was developed with the ultimate goal of providing an effective vaccine for infants and younger children. The conjugate vaccine is as safe as Hib polysaccharide vaccine and significantly more immunogenic. Because antibody production after vaccination with conjugate vaccine in children 18 months of age or older is ...
J J, Campion, D T, Casto
openaire   +2 more sources

Haemophilus influenzae type b unsuspected bacteremia

Pediatric Emergency Care, 1987
To further define the clinical features and natural history of unsuspected Haemophilus influenzae type b (Hib) bacteremia, we retrospectively reviewed the records of 322 Hib infections observed during a 45-month period at Children's Hospital, Boston. We identified 31 patients with unsuspected Hib bacteremia and 19 with unsuspected Hib antigenemia and ...
A B, Anderson, D M, Ambrosino, G R, Siber   +2 more
openaire   +2 more sources

Haemophilus influenzae Type b Conjugate Vaccines

1995
In summary, all of the Hib conjugate vaccines are highly immunogenic and efficacious in children older than 12-15 months of age, and HbOC, PRP-OMPC, and PRP-T are highly immunogenic and demonstrated to be efficacious in infants as young as 2 months old.
P J, Kniskern, S, Marburg, R W, Ellis
openaire   +2 more sources

Haemophilus Influenzae Type B (Hib)

2018
All infants without contraindications should receive the conjugate Hib vaccine series; either as 3 doses of PRP-OMP (trade name: PedvaxHIB®), or as 4 doses of PRP-T (trade names: ActHIB®, Hiberix®; also included in the DTaP-Hib-IPV combination vaccine Pentacel®).
Matthew Z. Dudley, Daniel A. Salmon, Neal A. Halsey, Walter A. Orenstein, Rupali J. Limaye, Sean T. O’Leary, Saad B. Omer   +6 more
openaire   +1 more source

Haemophilus influenzae type b vaccination

The Lancet, 1997
A, Melhus, A, Hemansson
openaire   +3 more sources